Laparoscopic instruments

LigaSure™ Maryland jaw thoracic sealer-divider with nano-coating

<p>The LigaSure™ Maryland jaw thoracic sealer-divider is a multifunctional nano-coated instrument designed for sealing pulmonary veins and arteries.</p>

Ordering information
Contact a representative

Features

Transform your thoracic procedures with the LigaSure™ Maryland jaw thoracic device

The multifunctional LigaSure™ Maryland jaw thoracic device complements thoracic procedures by providing:

  • One-step vessel sealing7

  • Enhanced blunt dissection†,8,9

  • Secure, atraumatic grasping†,8,9

  • Cold cutting independent of sealing7,8

The LigaSure™ technology difference

Reliable LigaSure™ vessel-sealing technology drives the LigaSure™ thoracic device. It works by using the body’s own collagen and elastin to create a permanent seal that is designed to withstand three times normal pulmonary systolic blood pressure.‡,10

Plus, LigaSure™ technology eliminates the guesswork — and minimizes thermal spread§,11 — by automatically discontinuing energy delivery when the seal cycle is complete.11

Learn how the LigaSure™ Maryland jaw and blunt tip devices were redesigned with sustainabilty in mind.

Please contact your local sales representative for additional information.

Specifications

 

Physical characteristics 
General Sterile, single use
Shaft length (cm) 23
Shaft rotation 350 degrees
Jaw design Curved
Seal plate length (mm) 20.3
Cut length (mm) 18.5
Foot switching yes
Generator compatibility Valleylab™ FT10 energy platform

 

Ordering information

Item number Description Length (cm) Units per box
LF1930T LigaSure™ Maryland jaw thoracic sealer-divider with nano-coating 30 6

Resources

Related links

Similar products

™* Third-party brands are trademarks of their respective owners. 

† 31 of 33 surgeons surveyed after use agreed. Compared to straight jaws.

 ‡ Bench testing model used to evaluate burst pressure of renal arteries. May not be indicative of clinical performance. Evidence: Testing performed on fresh porcine kidneys, using LigaSure devices % probability of a burst > 360 mmHg:  LF1212A (99.2%); LF1637 (96.8%); LF4318 (98.2%); and LS1037 (98.2%).

§ Based on systemic vasculature. Compared to Olympus Thunderbeat™*.

  1. Based on internal report RE00138840, Device length recommendation, thoracic (LF1930T). February 6, 2018.
  2. Based on internal test report RE00125866, Jaw range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on tissue. November 20–21, 2017 and November 27–30, 2017.
  3. Based on internal test report RE00134865, Burst pressure verification of pulmonary veins (LF1930T). January 17–18, 2018.
  4. Based on internal test report RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. January 8–10, 2018.
  5. Based on internal test report RE00128442, GLP acute pulmonary vasculature hemostasis verification study of the LF1930T in hounds. December 8, 2017.
  6. Based on internal report RE00147462, Pulmonary sealing claims for the LigaSure™ device (LF1930T). March 29, 2018.

  1. LigaSure™ Maryland jaw thoracic sealer/divider one-step sealing, nano-coated instructions for use. Medtronic, Boulder, CO; 2018.
  2. Based on internal test report RE00140529, rev A, LigaSure™ Maryland device, nano-coated (LF19XX) tissue testing (memo). March 5, 2018.
  3. Based on internal test report R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
  4. Based on Covidien ex-vivo Renal Burst Pressure report: Verification - Report - LigaSure™ Renal Bench Burst Pressure Evaluation of the Valleylab™ FT10. May 3, 2015; R0064457
  5. Based on internal test report RE00025819, rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.